CORE LABORATORIES INC (CLB) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CLB - US21867A1051 - Common Stock
14.72 USD
+0.83 (+5.98%)
14.72 USD
0 (0%)
Taking everything into account, CLB scores 5 out of 10 in our fundamental rating. CLB was compared to 60 industry peers in the Energy Equipment & Services industry. CLB has an excellent financial health rating, but there are some minor concerns on its profitability. CLB has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CLB was profitable.
In the past year CLB had a positive cash flow from operations.
Of the past 5 years CLB 4 years were profitable.
In the past 5 years CLB always reported a positive cash flow from operatings.
1.2 Ratios
CLB has a better Return On Assets (5.43%) than 68.33% of its industry peers.
CLB's Return On Equity of 11.84% is fine compared to the rest of the industry. CLB outperforms 70.00% of its industry peers.
CLB's Return On Invested Capital of 9.29% is fine compared to the rest of the industry. CLB outperforms 71.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLB is in line with the industry average of 7.76%.
The last Return On Invested Capital (9.29%) for CLB is above the 3 year average (8.80%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROIC | 9.29% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
1.3 Margins
CLB has a Profit Margin of 6.21%. This is comparable to the rest of the industry: CLB outperforms 58.33% of its industry peers.
In the last couple of years the Profit Margin of CLB has declined.
CLB's Operating Margin of 11.16% is in line compared to the rest of the industry. CLB outperforms 60.00% of its industry peers.
CLB's Operating Margin has declined in the last couple of years.
CLB has a Gross Margin of 19.95%. This is in the lower half of the industry: CLB underperforms 70.00% of its industry peers.
CLB's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% |
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
The number of shares outstanding for CLB remains at a similar level compared to 1 year ago.
The number of shares outstanding for CLB has been increased compared to 5 years ago.
Compared to 1 year ago, CLB has an improved debt to assets ratio.
2.2 Solvency
CLB has an Altman-Z score of 3.17. This indicates that CLB is financially healthy and has little risk of bankruptcy at the moment.
CLB has a better Altman-Z score (3.17) than 81.67% of its industry peers.
CLB has a debt to FCF ratio of 3.32. This is a good value and a sign of high solvency as CLB would need 3.32 years to pay back of all of its debts.
The Debt to FCF ratio of CLB (3.32) is better than 65.00% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that CLB is not too dependend on debt financing.
The Debt to Equity ratio of CLB (0.42) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 3.17 |
ROIC/WACC1.07
WACC8.66%
2.3 Liquidity
CLB has a Current Ratio of 2.37. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
CLB's Current ratio of 2.37 is fine compared to the rest of the industry. CLB outperforms 68.33% of its industry peers.
CLB has a Quick Ratio of 1.76. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
CLB has a Quick ratio of 1.76. This is in the better half of the industry: CLB outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 |
3. Growth
3.1 Past
CLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.41%.
The earnings per share for CLB have been decreasing by -13.14% on average. This is quite bad
The Revenue has decreased by -1.02% in the past year.
CLB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.75% yearly.
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
3.2 Future
The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
Based on estimates for the next years, CLB will show a small growth in Revenue. The Revenue will grow by 3.47% on average per year.
EPS Next Y-17.36%
EPS Next 2Y-1.48%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue Next Year-2.71%
Revenue Next 2Y0.74%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.12 indicates a rather expensive valuation of CLB.
65.00% of the companies in the same industry are more expensive than CLB, based on the Price/Earnings ratio.
CLB is valuated rather cheaply when we compare the Price/Earnings ratio to 25.45, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 17.23, CLB is valued on the expensive side.
CLB's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.46, CLB is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.12 | ||
| Fwd PE | 17.23 |
4.2 Price Multiples
85.00% of the companies in the same industry are cheaper than CLB, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLB is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.08 | ||
| EV/EBITDA | 10.75 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.48%
EPS Next 3Y-0.94%
5. Dividend
5.1 Amount
With a yearly dividend of 0.29%, CLB is not a good candidate for dividend investing.
CLB's Dividend Yield is comparable with the industry average which is at 3.01.
Compared to an average S&P500 Dividend Yield of 2.42, CLB's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.29% |
5.2 History
The dividend of CLB decreases each year by -55.13%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
5.83% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP5.83%
EPS Next 2Y-1.48%
EPS Next 3Y-0.94%
14.72
+0.83 (+5.98%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners114.84%
Inst Owner Change-87.66%
Ins Owners1.04%
Ins Owner Change0.07%
Market Cap690.22M
Revenue(TTM)517.50M
Net Income(TTM)32.12M
Analysts48
Price Target15.64 (6.25%)
Short Float %11.89%
Short Ratio9.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.29% |
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.83%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-0.33%
Max EPS beat(2)12.86%
EPS beat(4)1
Avg EPS beat(4)1.9%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)4
Avg EPS beat(8)4.82%
EPS beat(12)7
Avg EPS beat(12)5.16%
EPS beat(16)8
Avg EPS beat(16)3.39%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)11.51%
PT rev (3m)11.51%
EPS NQ rev (1m)1.83%
EPS NQ rev (3m)-4.31%
EPS NY rev (1m)-4.09%
EPS NY rev (3m)-3.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.12 | ||
| Fwd PE | 17.23 | ||
| P/S | 1.33 | ||
| P/FCF | 20.08 | ||
| P/OCF | 13.89 | ||
| P/B | 2.54 | ||
| P/tB | 4.18 | ||
| EV/EBITDA | 10.75 |
EPS(TTM)0.77
EY5.23%
EPS(NY)0.85
Fwd EY5.8%
FCF(TTM)0.73
FCFY4.98%
OCF(TTM)1.06
OCFY7.2%
SpS11.04
BVpS5.79
TBVpS3.52
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROCE | 11.66% | ||
| ROIC | 9.29% | ||
| ROICexc | 9.8% | ||
| ROICexgc | 12.66% | ||
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% | ||
| FCFM | 6.64% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexgc growth 3Y11.32%
ROICexgc growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score7
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | 1.58 | ||
| Cap/Depr | 104.6% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 6.66 | ||
| Cash Conversion | 68.62% | ||
| Profit Quality | 107.03% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 | ||
| Altman-Z | 3.17 |
F-Score7
WACC8.66%
ROIC/WACC1.07
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
EPS Next Y-17.36%
EPS Next 2Y-1.48%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
Revenue Next Year-2.71%
Revenue Next 2Y0.74%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-6.83%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year8.35%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y286.32%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y165.78%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%
CORE LABORATORIES INC / CLB FAQ
Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?
ChartMill assigns a fundamental rating of 5 / 10 to CLB.
What is the valuation status for CLB stock?
ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.
Can you provide the profitability details for CORE LABORATORIES INC?
CORE LABORATORIES INC (CLB) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CLB stock?
The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 19.12 and the Price/Book (PB) ratio is 2.54.
Can you provide the financial health for CLB stock?
The financial health rating of CORE LABORATORIES INC (CLB) is 7 / 10.